464 related articles for article (PubMed ID: 15548666)
1. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
[TBL] [Abstract][Full Text] [Related]
2. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
3. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
4. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
Li S; Kim JE; Budel S; Hampton TG; Strittmatter SM
Mol Cell Neurosci; 2005 May; 29(1):26-39. PubMed ID: 15866044
[TBL] [Abstract][Full Text] [Related]
5. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells.
Huang JY; Wang YX; Gu WL; Fu SL; Li Y; Huang LD; Zhao Z; Hang Q; Zhu HQ; Lu PH
Brain Res; 2012 Feb; 1437():1-15. PubMed ID: 22227458
[TBL] [Abstract][Full Text] [Related]
7. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma.
Cafferty WB; Duffy P; Huebner E; Strittmatter SM
J Neurosci; 2010 May; 30(20):6825-37. PubMed ID: 20484625
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
Ji B; Li M; Budel S; Pepinsky RB; Walus L; Engber TM; Strittmatter SM; Relton JK
Eur J Neurosci; 2005 Aug; 22(3):587-94. PubMed ID: 16101740
[TBL] [Abstract][Full Text] [Related]
9. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
[TBL] [Abstract][Full Text] [Related]
10. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
11. Expression of oligodendrocyte myelin glycoprotein and its receptor NgR after the injury of rat central nervous system.
Guo Q; Li S; Su B
Neurosci Lett; 2007 Jul; 422(2):103-8. PubMed ID: 17630211
[TBL] [Abstract][Full Text] [Related]
12. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
Nyatia E; Lang DM
Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
[TBL] [Abstract][Full Text] [Related]
13. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
Hunt D; Coffin RS; Anderson PN
J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
[TBL] [Abstract][Full Text] [Related]
14. Activity-induced and developmental downregulation of the Nogo receptor.
Josephson A; Trifunovski A; Schéele C; Widenfalk J; Wahlestedt C; Brené S; Olson L; Spenger C
Cell Tissue Res; 2003 Mar; 311(3):333-42. PubMed ID: 12658441
[TBL] [Abstract][Full Text] [Related]
15. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice.
Lee JK; Geoffroy CG; Chan AF; Tolentino KE; Crawford MJ; Leal MA; Kang B; Zheng B
Neuron; 2010 Jun; 66(5):663-70. PubMed ID: 20547125
[TBL] [Abstract][Full Text] [Related]
16. Blockade of Nogo receptor ligands promotes functional regeneration of sensory axons after dorsal root crush.
Harvey PA; Lee DH; Qian F; Weinreb PH; Frank E
J Neurosci; 2009 May; 29(19):6285-95. PubMed ID: 19439606
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.
Robak LA; Venkatesh K; Lee H; Raiker SJ; Duan Y; Lee-Osbourne J; Hofer T; Mage RG; Rader C; Giger RJ
J Neurosci; 2009 May; 29(18):5768-83. PubMed ID: 19420245
[TBL] [Abstract][Full Text] [Related]
18. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
Liu BP; Fournier A; GrandPré T; Strittmatter SM
Science; 2002 Aug; 297(5584):1190-3. PubMed ID: 12089450
[TBL] [Abstract][Full Text] [Related]
19. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
Cao Y; Shumsky JS; Sabol MA; Kushner RA; Strittmatter S; Hamers FP; Lee DH; Rabacchi SA; Murray M
Neurorehabil Neural Repair; 2008; 22(3):262-78. PubMed ID: 18056009
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
